Aunima R. Bhuiya

Aunima R. Bhuiya

Auto-generated profile, based on publicly available information

Aunima R. Bhuiya

(∗)North York General Hospital, 4001 Leslie Street, Toronto, Ontario, Canada, M2K 1E1; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Toronto, Ontario, Canada, M5T 3M6

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2023 in Journal of Medical Internet Research
Verified
Journal Article
Open access
PVPaula Voorheis
Paula Voorheis
ABAunima R Bhuiya
Aunima R Bhuiya
KKKerry Kuluski
Kerry Kuluski
QPQuynh Pham
Quynh Pham
JPJeremy Petch
Jeremy Petch
Background: Digital health interventions are increasingly being designed to support health behaviors. Although digital health interventions informed by behavioral science theories, models, and frameworks (TMFs) are more likely to be effective than those designed without them, design teams often struggle to use these evidence-informed tools. Until now, little work has been done to clarify the ways in which behavioral science TMFs can add value to digital health design. Objective: The aim of this study was to better understand how digital health design leaders select and use TMFs in design practice. The questions that were addressed included how do design leaders perceive the value of TMFs in digital health design, what considerations do design leaders make when selecting and applying TMFs, and what do design leaders think is needed in the future to advance the utility of TMFs in digital health design? Methods: This study used a qualitative description design to understand the experiences and perspectives of digital health design leaders. The participants were identified through purposive and snowball sampling. Semistructured interviews were conducted via Zoom software. Interviews were audio-recorded and transcribed using Otter.ai software. Furthermore, 3 researchers coded a sample of interview transcripts and confirmed the coding strategy. One researcher completed the qualitative analysis using a codebook thematic analysis approach. Results: Design leaders had mixed opinions on the value of behavioral science TMFs in digital health design. Leaders suggested that TMFs added the most value when viewed as a starting point rather than the final destination for evidence-informed design. Specifically, these tools added value when they acted as a gateway drug to behavioral science, supported health behavior conceptualization, were balanced with expert knowledge and user-centered design principles, were complementary to existing design methods, and supported both individual- and systems-level thinking. Design leaders also felt that there was a considerable nuance in selecting the most value-adding TMFs. Considerations should be made regarding their source, appropriateness, complexity, accessibility, adaptability, evidence base, purpose, influence, audience, fit with team expertise, fit with team culture, and fit with external pressures. Design leaders suggested multiple opportunities to advance the use of TMFs. These included improving TMF reporting, design, and accessibility, as well as improving design teams' capacity to use TMFs appropriately in practice. Conclusions: When designing a digital health behavior change intervention, using TMFs can help design teams to systematically integrate behavioral insights. The future of digital health behavior change design demands an easier way for designers to integrate evidence-based TMFs into practice.

8 May 2025 in Journal of Diabetes Science and Technology
Verified
Journal Article
Closed access
PVPaula Voorheis
Paula Voorheis
JWJulia Victoria Wong
Julia Victoria Wong
NLNatasa Lazarevic
Natasa Lazarevic
BIBisma Imtiaz
Bisma Imtiaz
ABAunima Bhuiya
Aunima Bhuiya
CGCarolyn Steele Gray
Carolyn Steele Gray
Introduction: Solutions to support disease self-management and health-related behavior changes require a deep understanding of patient experiences, needs, and challenges across the care journey. Journey mapping (JM) and service blueprinting (SB) are valuable tools for visualizing user experiences and system processes over time. This scoping review explores how JM/SBs have been applied to design digitally enabled interventions targeting health-related behaviors among patients and the public. Methods: The JBI reviewer manual was used to guide the review. Studies were sourced from Embase, Psych Info, PubMed, Medline, Web of Science, and Scopus. Inclusion criteria required studies to describe how JM/SBs informed the design of a digitally enabled health innovation that aimed to impact health or health care-related behaviors of patients or the public. A two-level screening process and iterative data extraction were applied. Results: A total of 28 studies met the inclusion criteria, with a majority published between 2019 and 2024. The JM/SBs rarely used behavioral science theory and were structured, organized, and presented in diverse ways. Most studies designed their digital health behavior change innovations by using JM/SB to identify relevant innovation touchpoints across the patient journey. Patients frequently participated in the digital health behavior change innovation design process, with JM/SBs often serving as sensemaking tools. Innovations tended to address multifaceted health service problems through multimodal, digitally enabled solutions. Conclusions: JM/SBs are emerging as versatile tools to help digital health innovations to conduct user research, engage diverse partners, identify complex problems, and ideate creative solutions. However, limited integration of behavioral science theory indicates an area for future exploration.

20 October 2021 in American Journal of Preventive Medicine
Verified
Journal Article
Closed access
SSSharada S. Shantharam
Sharada S. Shantharam
MMMallika Mahalingam
Mallika Mahalingam
ARAysha Rasool
Aysha Rasool
JRJeffrey A. Reynolds
Jeffrey A. Reynolds
ABAunima R. Bhuiya
Aunima R. Bhuiya
DHDavid P. Hopkins
David P. Hopkins

20 April 2022 in JMIR Aging
Verified
Journal Article
Open access
RMRafael N Miranda
Rafael N Miranda
ABAunima R Bhuiya
Aunima R Bhuiya
ZTZak Thraya
Zak Thraya
RHRebecca Hancock-Howard
Rebecca Hancock-Howard
BCBrian Cf Chan
Brian Cf Chan
KTKednapa Thavorn
Kednapa Thavorn
Background: eHealth technologies for self-management can improve quality of life, but little is known about whether the benefits gained outweigh their costs. The electronic patient-reported outcome (ePRO) mobile app and portal system supports patients with multiple chronic conditions to collaborate with primary health care providers to set and monitor health-related goals. Objective: This study aims to estimate the cost of ePRO and the cost utility of the ePRO intervention compared with usual care provided to patients with multiple chronic conditions and complex needs living in the community, from the perspective of the publicly funded health care payer in Ontario, Canada. Methods: We developed a decision tree model to estimate the incremental cost per quality-adjusted life year (QALY) gained for the ePRO tool versus usual care over a time horizon of 15 months. Resource utilization and effectiveness of the ePRO tool were drawn from a randomized clinical trial with 6 family health teams involving 45 participants. Unit costs associated with health care utilization (adjusted to 2020 Canadian dollars) were drawn from literature and publicly available sources. A series of sensitivity analyses were conducted to assess the robustness of the findings. Results: The total cost of the ePRO tool was CAD $79,467 (~US $ 63,581; CAD $1733 [~US $1386] per person). Compared with standard care, the ePRO intervention was associated with higher costs (CAD $1710 [~US $1368]) and fewer QALYs (–0.03). The findings were consistent with the clinical evidence, suggesting no statistical difference in health-related quality of life between ePRO and usual care groups. However, the tool would be considered a cost-effective option if it could improve by at least 0.03 QALYs. The probability that the ePRO is cost-effective was 17.3% at a willingness-to-pay (WTP) threshold of CAD $50,000 (~US $40,000)/QALY. Conclusions: The ePRO tool is not a cost-effective technology at the commonly used WTP value of CAD $50,000 (~US $40,000)/QALY, but long-term and the societal impacts of ePRO were not included in this analysis. Further research is needed to better understand its impact on long-term outcomes and in real-world settings. The present findings add to the growing evidence about eHealth interventions’ capacity to respond to complex aging populations within finite-resourced health systems. Trial Registration: ClinicalTrials.gov NCT02917954; https://clinicaltrials.gov/ct2/show/NCT02917954

7 November 2023 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
ABAunima R. Bhuiya
Aunima R. Bhuiya
JSJustin Sutherland
Justin Sutherland
RBRhonda Boateng
Rhonda Boateng
TBTéjia Bain
Téjia Bain
BSBecky Skidmore
Becky Skidmore
MKMonika Kastner
Monika Kastner
To identify candidate quality indicators from existing tools that provide guidance on how to practice knowledge translation and implemenation science (KT practice tools) across KT domains (dissemination, implementation, sustainability, and scalability). We conducted a scoping review using the Joanna Briggs Institute Manual for Evidence Synthesis. We systematically searched multiple electronic databases and the gray literature. Documents were independently screened, selected, and extracted by pairs of reviewers. Data about the included articles, KT practice tools, and candidate quality indicators were analyzed, categorized, and summarized descriptively. Of 43,060 titles and abstracts that were screened from electronic databases and gray literature, 850 potentially relevant full-text articles were identified, and 253 articles were included in the scoping review. Of these, we identified 232 unique KT practice tools from which 27 unique candidate quality indicators were generated. The identified candidate quality indicators were categorized according to the development (n = 17), evaluation (n = 5) and adaptation (n = 3) of the tools, and engagement of knowledge users (n = 2). No tools were identified that appraised the quality of KT practice tools. The development of a quality appraisal instrument of KT practice tools is needed. The results will be further refined and finalized in order to develop a quality appraisal instrument for KT practice tools.

19 September 2022 in JBI Evidence Synthesis
Verified
Journal Article
Closed access
ABAunima R. Bhuiya
Aunima R. Bhuiya
JMJulie Makarski
Julie Makarski
LHLeigh Hayden
Leigh Hayden
LPLaure Perrier
Laure Perrier
SMSarah Munce
Sarah Munce
MKMonika Kastner
Monika Kastner
Objective: The objective of this scoping review is to identify and characterize relevant knowledge translation methods tools (those that provide guidance for optimized knowledge translation practice) to uncover candidate quality indicators to inform a future quality assessment tool for knowledge translation strategies. Introduction: Knowledge translation strategies (defined as including knowledge translation interventions, tools, and products) target various knowledge users, including patients, clinicians, researchers, and policy-makers. The development and use of strategies that support knowledge translation practice have been rapidly increasing, making it difficult for knowledge users to decide which to use. There is limited evidence-based guidance or measures to help assess the overall quality of knowledge translation strategies. Inclusion criteria: Empirical and non-empirical documents will be considered if they explicitly describe a knowledge translation methods tool and its development, evaluation or validation, methodological strengths or limitations, and/or use over time. The review will consider a knowledge translation methods tool if it falls within at least one knowledge translation domain (ie, implementation, dissemination, sustainability, scalability, integrated knowledge translation) in the health field. Methods: We will conduct a systematic search of relevant electronic databases and gray literature. The search strategy will be developed iteratively by an experienced medical information specialist and peer-reviewed with the PRESS checklist. The search will be limited to English-only documents published from 2005 onward. Documents will be independently screened, selected, and extracted by 2 researchers. Data will be analyzed and summarized descriptively, including the characteristics of the included documents, knowledge translation methods tools, and candidate quality indicators. Scoping review registration: Open Science Framework (https://osf.io/chxvq)